|
Miltenyi Biotec
peptivator ovalbumin olp Peptivator Ovalbumin Olp, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/PepTivator+Ovalbumin%2C+research+grade/pmc13220859-274-16-19 Average 93 stars, based on 1 article reviews
peptivator ovalbumin olp - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Twist Bioscience
300 nt single stranded pooled oligos 300 Nt Single Stranded Pooled Oligos, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/Tier+1%2C+up+to+2K+oligos/bio_rxiv__64898__2026__03__11__711047-220-12-16 Average 94 stars, based on 1 article reviews
300 nt single stranded pooled oligos - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Twist Bioscience
tier 1 ssdna oligo pool Tier 1 Ssdna Oligo Pool, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/Tier+1%2C+up+to+2K+oligos/pm41792242-277-8-4 Average 94 stars, based on 1 article reviews
tier 1 ssdna oligo pool - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Twist Bioscience
oligos Oligos, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/Tier+1%2C+up+to+2K+oligos/pm41792242-313-0-4 Average 94 stars, based on 1 article reviews
oligos - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
peptide olp pools Peptide Olp Pools, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/PepTivator+SARS-CoV-2+Prot_S+Complete%2C+research+grade/pm41759750-102-17-24 Average 96 stars, based on 1 article reviews
peptide olp pools - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Peptron Inc
peptide olp pool ![]() Peptide Olp Pool, supplied by Peptron Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/olp+peptide+pool/pmc13133369-424-10-20 Average 86 stars, based on 1 article reviews
peptide olp pool - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Picarro Inc
olp ![]() Olp, supplied by Picarro Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/G2301/10__5194_slash_acp___25___18509___2025-75-7-9 Average 97 stars, based on 1 article reviews
olp - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
GenScript corporation
11–15-mer synthetic olps corresponding to each 25-mer neoantigen vaccine peptide ![]() 11–15 Mer Synthetic Olps Corresponding To Each 25 Mer Neoantigen Vaccine Peptide, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/11+15+mer+synthetic+olps+corresponding+to+each+25+mer+neoantigen+vaccine+peptide/pm40346292-211-9-12 Average 90 stars, based on 1 article reviews
11–15-mer synthetic olps corresponding to each 25-mer neoantigen vaccine peptide - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
peptivator sars-cov-2 prot_s complete, research grade ![]() Peptivator Sars Cov 2 Prot S Complete, Research Grade, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/PepTivator+SARS-CoV-2+Prot_S+Complete%2C+research+grade/custom%40130-127-951%4040259456 Average 96 stars, based on 1 article reviews
peptivator sars-cov-2 prot_s complete, research grade - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Glac Biotech Co Ltd
bifidobacterium longum subsp. longum olp-01 ![]() Bifidobacterium Longum Subsp. Longum Olp 01, supplied by Glac Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/bifidobacterium+animalis+subsp++lactis+cp+9/pm40004951-112-4-25 Average 90 stars, based on 1 article reviews
bifidobacterium longum subsp. longum olp-01 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: NPJ Vaccines
Article Title: Development of a Prophylactic mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome Using HSA based LNP
doi: 10.1038/s41541-026-01385-0
Figure Lengend Snippet: A . Immunoglobulin level analysis. Total levels of IgG1, IgG2b, IgG3, IgA, and IgM in BALB/c (top), C57BL/6 (middle), and IFNAR – / – (bottom) mice were examined using flow cytometry or P-ELISA before and after receiving either 1 or 10 µg of HSAmvac on days 0, 14, 28, and 42. Data are presented as means ± SD for three mice. * p < 0.05, ** p < 0.01, ** p < 0.001, and **** p < 0.0001. A two-way or one-way ANOVA with Holm–Sidak multiple comparison test was used, comparing results to the corresponding control (Ctrl; day 0). An unpaired t-test was performed when comparing the low-dose (1 µg) group. B Neutralizing antibody titers (FRNT₅₀) were measured on days 0, 14, and 28 in BALB/c, C57BL/6, and IFNAR⁻/⁻ mice vaccinated with either 1 µg or 10 µg of HSAmvac. Data are presented as means ± SD for three mice. Statistical analysis was performed using a two-way or one-way ANOVA with Holm–Sidak multiple comparison test, comparing results to the corresponding control (Ctrl; day 0). An unpaired t-test (Mann–Whitney test) was used for comparison to the group that received 1 µg of HSAmvac. C BALB/c, C57BL/6, and IFNAR – / – mice received a prime–booster immunization with HSAmvac at 2-week intervals. The SFTSV antigen-specific cytokine response was assessed following in vitro activation of splenocytes. Cells were restimulated with an overlapping peptide pool (2 μg/mL per peptide) spanning the SFTSV nucleoprotein (N) using the SFTSV OLP peptide pool. Cells were harvested from mice pre- and post-SFTSV challenge for intracellular cytokine staining. The percentage of cells producing cytokines, including IFN-γ, IL-2, IL-4, and TNF-α, was determined by flow cytometry. Data are presented as means ± SD for three mice. * p < 0.05, ** p < 0.01, *** p < 0.001, and ** p < 0.0001. A two-way or one-way ANOVA with Holm–Sidak multiple comparison test was used, as compared to the corresponding control (Ctrl; day 0). An unpaired t-test (Mann–Whitney test) was used for comparison with the group that received 1 µg of HSAmvac.
Article Snippet: Splenocytes were restimulated in vitro with a commercially synthesized overlapping
Techniques: Flow Cytometry, Enzyme-linked Immunosorbent Assay, Comparison, Control, MANN-WHITNEY, In Vitro, Activation Assay, Staining
Journal: NPJ Vaccines
Article Title: Development of a Prophylactic mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome Using HSA based LNP
doi: 10.1038/s41541-026-01385-0
Figure Lengend Snippet: Sera were collected either before or after the challenge at 1, 3, and 7 dpi. Mock groups or pre-challenged mouse groups were used as controls for comparison. A Antibody responses were assessed by quantifying IgG1, IgG2b, IgG3, IgA, and IgM titers in BALB/c (left), C57BL/6 (middle), and IFNAR – / – (right) mice using immunoassays such as bead-based assay and P-ELISA. Data are means ± SD of three mice. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 compared with pre-challenge groups by Two-way ANOVA test with Holm–Sidak’s multiple comparisons. Comparison with the mock group was done using an unpaired t-test (Mann–Whitney test). B Splenocytes were collected from BALB/c, C57BL/6, and IFNAR – / – mice that were immunized with either mock or HSAmvac, before or after the challenge at 1, 3, and 7 dpi. Either mock groups or pre-challenged mouse groups were used as control comparisons. Cellular cytokine responses in CD4⁺ and CD8⁺ T cells to the SFTSV OLP peptide pool were evaluated by performing intracellular cytokine staining with activated splenocytes, followed by flow cytometry. Pre- and post-challenge levels of IFN-γ, IL-2, IL-4, and TNF-α were determined for CD4 ⁺ and CD8 ⁺ T cells. Data are presented as means ± SD of three mice. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.001. Two-way ANOVA test with Holm–Sidak multiple comparison test, as com p ared to the corresponding control (Ctrl). Comparison with the low-dose group was done using an unpaired t-test (Mann–Whitney test).
Article Snippet: Splenocytes were restimulated in vitro with a commercially synthesized overlapping
Techniques: Comparison, Bead-based Assay, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY, Control, Staining, Flow Cytometry